72 related articles for article (PubMed ID: 108635)
1. [Acromegaly. Recent physiopathological and therapeutic acquisitions].
Silvestrini F
Minerva Med; 1979 Mar; 70(15):1065-8. PubMed ID: 108635
[No Abstract] [Full Text] [Related]
2. [Acromegaly. Physiopathological aspects and description of a clinical case].
Coppola A; Spera C; Buono V; Esposito C; Nasti A
Minerva Med; 1986 Mar; 77(11):395-401. PubMed ID: 3085021
[TBL] [Abstract][Full Text] [Related]
3. Dopaminergic control of growth hormone secretion in normal and acromegalic subjects.
Molinatti GM; Camanni F; Massara F; Isaia GC
Panminerva Med; 1975 Apr; 17(4):101-6. PubMed ID: 1153217
[No Abstract] [Full Text] [Related]
4. Conventional pituitary irradiation in acromegaly. Effect on growth hormone and TSH secretion.
Lamberg BA; Kivikangas V; Vartianen J; Raitta C; Pelkonen R
Acta Endocrinol (Copenh); 1976 Jun; 82(2):267-81. PubMed ID: 818860
[TBL] [Abstract][Full Text] [Related]
5. [Study of growth hormone under the effects of L-dopa in retardation of stature and acromegaly].
Fossati P; Asfour M; Fourlinnie JC; Cappoen JP; Dalle-Furnari MA; Brion-Brevan B
Lille Med; 1976 Nov; 19(9):757-65. PubMed ID: 1004102
[No Abstract] [Full Text] [Related]
6. [Determination of growth hormone response to thyreoliberin in the evaluation of lisuride therapy of acromegaly].
Felt V; Nedvídková J
Vnitr Lek; 1982 Aug; 28(8):756-61. PubMed ID: 6814061
[No Abstract] [Full Text] [Related]
7. Growth hormone and changes in the secretion of thyrotropic hormone after thyrotropin-releasing hormone (TRH): ineffectiveness of dopaminergic stimulation.
Felt V; Nedvídková J
Endokrinologie; 1982 Oct; 80(2):201-6. PubMed ID: 6819130
[No Abstract] [Full Text] [Related]
8. Effects of thyrotropin-releasing hormone on growth hormone release in normal subjects and in patients with depression, anorexia nervosa and acromegaly.
Maeda K
Kobe J Med Sci; 1976 Dec; 22(4):263-72. PubMed ID: 829578
[No Abstract] [Full Text] [Related]
9. [Effect of somatostatin and bromocriptin (CB-154) on growth hormone secretion in acromegaly].
Althoff PH; Neubauer M; Handzel R; Schöffling K
Verh Dtsch Ges Inn Med; 1975; 81():1515-20. PubMed ID: 1243836
[No Abstract] [Full Text] [Related]
10. Dynamic testing in the diagnosis and follow-up of patients with acromegaly.
Wass JA
J Endocrinol Invest; 2003; 26(7 Suppl):48-53. PubMed ID: 14604066
[TBL] [Abstract][Full Text] [Related]
11. [Bromocryptin effect on growth hormone and prolactin secretion after administration of thyrotropin-releasing hormone in patients with primary hypothyroidism and acromegaly (author's transl)].
Felt V; Nedvídková J; Krejcík L; Hainer V
Cas Lek Cesk; 1977 May; 116(19):591-4. PubMed ID: 406999
[No Abstract] [Full Text] [Related]
12. Dynamics of growth hormone secretion in untreated acromegaly.
Dash RJ; Rao NS; Sriprakash ML; Sialy R
J Assoc Physicians India; 1987 May; 35(5):341-3. PubMed ID: 3121582
[No Abstract] [Full Text] [Related]
13. [Dynamic evaluation of GH secretion in acromegaly as a criterion for the choice of treatment].
Jannì A; Carmina E; Lanzara P; Lo Coco R; Longo RA
Clin Ter; 1977 Aug; 82(3):203-12. PubMed ID: 410583
[No Abstract] [Full Text] [Related]
14. Growth hormone hypersecretion and acromegaly.
Daughaday WH; Cryer PE
Hosp Pract; 1978 Aug; 13(8):75-80. PubMed ID: 99362
[No Abstract] [Full Text] [Related]
15. Long-term treatment of acromegaly with Sandostatin (SMS 201-995). Normalization of most anomalous growth hormone responses.
Pieters GF; van Liessum PA; Smals AG; van Gennep JA; Benraad TJ; Kloppenborg PW
Acta Endocrinol Suppl (Copenh); 1987; 286():9-18. PubMed ID: 2892339
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone dynamics in acromegaly.
Lawrence AM; Goldfine ID; Kirsteins L
J Clin Endocrinol Metab; 1970 Sep; 31(3):239-47. PubMed ID: 4916537
[No Abstract] [Full Text] [Related]
17. [Effects on growth hormone secretion of a new somatostatin analogue (SMS 201-995) and nonspecific releasing hormones in patients with acromegaly].
Candrina R
Medicina (Firenze); 1988; 8(2):180-1. PubMed ID: 3147351
[No Abstract] [Full Text] [Related]
18. [The effects of somatostatin in acromegaly].
Schaison G; Roger M; Milhaud G
Nouv Presse Med; 1976 Mar; 5(10):629-32. PubMed ID: 772591
[TBL] [Abstract][Full Text] [Related]
19. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
Ishibashi M; Yamaji T
J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
[TBL] [Abstract][Full Text] [Related]
20. Somatostatin: a review of its effects especially in human beings.
Hansen AP; Lundbaek K
Diabete Metab; 1976 Dec; 2(4):203-18. PubMed ID: 190058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
